Methocarbamol and Xpovio drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Methocarbamol (methocarbamol) and Xpovio (selinexor). Common drug interactions include plasma cell myeloma among males.
The phase IV clinical study analyzes what interactions people have when they take Methocarbamol and Xpovio. It is created by eHealthMe based on reports of 26 people who take the same drugs from the FDA, and is updated regularly.
What is Methocarbamol?
Methocarbamol has active ingredients of methocarbamol. It is often used in muscle spasms. eHealthMe is studying from 17,766 Methocarbamol users. Check the latest studies of Methocarbamol.
What is Xpovio?
Xpovio has active ingredients of selinexor. eHealthMe is studying from 5,193 Xpovio users. Check the latest studies of Xpovio.
26 people who take Methocarbamol and Xpovio together, and have interactions are studied.
What are the common drug interactions of Methocarbamol and Xpovio, by gender? *:
female:
n/a
male:
- Plasma cell myeloma (cancer that begins in plasma cells)
What are the common drug interactions of Methocarbamol and Xpovio, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Plasma cell myeloma (cancer that begins in plasma cells)
50-59:
n/a
60+:
n/a
What are the existing conditions these people have? *
- Multiple Myeloma (cancer of the plasma cells): 21 people, 80.77%
- Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 5 people, 19.23%
- Pain: 3 people, 11.54%
- Nausea (feeling of having an urge to vomit): 2 people, 7.69%
- Diarrhea: 2 people, 7.69%
* Approximation only. Some reports may have incomplete information.
Do you take Methocarbamol and Xpovio?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Methocarbamol (17,766 reports)
- Xpovio (5,193 reports)
Browse all drug interactions of Methocarbamol and Xpovio:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Methocarbamol:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Xpovio:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Methocarbamol and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Xpovio and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on methocarbamol and selinexor (the active ingredients of Methocarbamol and Xpovio, respectively), and Methocarbamol and Xpovio (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Zenatane cause Heart Palpitations? - 3 seconds ago
- Drug interactions of Geodon and Potassium - 4 seconds ago
- Bone Density Decreased and Diarrhea - 5 seconds ago
- Bone Density Decreased and Stools - Watery - 5 seconds ago
- Could Sertraline cause Abdominal Infection? - 6 seconds ago
- Drug interactions of Truvada and Apixaban - 8 seconds ago
- Could Xiaflex cause Abdominal Pain? - 14 seconds ago
- Could Reyataz cause Dermatitis - Atopic? - 18 seconds ago
- Could Reyataz cause Eczema? - 18 seconds ago
- Could Ginkgo cause Decreased Interest? - 19 seconds ago